tradingkey.logo

electroCore, Inc.

ECOR
5.450USD
+0.380+7.50%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
41.61MMarktkapitalisierung
VerlustKGV TTM

electroCore, Inc.

5.450
+0.380+7.50%

mehr Informationen über electroCore, Inc. Unternehmen

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform and related product offerings. The Company’s portfolio also includes Quell, a wearable, app and cloud-enabled neuromodulation platform that is indicated for the treatment of fibromyalgia symptoms and lower-extremity chronic pain. Its product categories include handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headaches, and handheld, personal use consumer products. Its products include gammaCore, Quell Fibromyalgia, Truvaga and TAC-STIM. Its gammaCore Sapphire is a prescription medical device that is used for a variety of primary headache conditions. Truvaga is a personal-use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com.

electroCore, Inc. Informationen

BörsenkürzelECOR
Name des UnternehmenselectroCore, Inc.
IPO-datumJun 22, 2018
CEOGoldberger (Daniel S)
Anzahl der mitarbeiter73
WertpapierartOrdinary Share
GeschäftsjahresendeJun 22
Addresse200 Forge Way
StadtROCKAWAY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl07866
Telefon19732900097
Websitehttps://www.electrocore.com/
BörsenkürzelECOR
IPO-datumJun 22, 2018
CEOGoldberger (Daniel S)

Führungskräfte von electroCore, Inc.

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie A. Goldstein
Ms. Julie A. Goldstein
Independent Director
Independent Director
--
--
Mr. Joshua S. Lev
Mr. Joshua S. Lev
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James C. Theofilos
Mr. James C. Theofilos
Director
Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Daniel S. (Dan) Goldberger
Mr. Daniel S. (Dan) Goldberger
Chief Executive Officer, Director
Chief Executive Officer, Director
232.27K
+46375.00%
Mr. Thomas M. (Tom) Patton, J.D.
Mr. Thomas M. (Tom) Patton, J.D.
Independent Director
Independent Director
102.78K
+19011.00%
Mr. John P. Gandolfo
Mr. John P. Gandolfo
Independent Director
Independent Director
88.10K
+19011.00%
Ms. Patricia Wilber
Ms. Patricia Wilber
Independent Director
Independent Director
72.33K
+19011.00%
Ms. Elena Bonfiglioli
Ms. Elena Bonfiglioli
Director
Director
30.55K
+30549.00%
Dr. Thomas J. Errico, M.D.
Dr. Thomas J. Errico, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%
Nach RegionUSD
Name
Umsatz
Anteil
United States
8.22M
94.63%
United Kingdom
402.00K
4.63%
Other
48.00K
0.55%
Japan
17.00K
0.20%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Health and Wellness Products
6.81M
78.37%
Prescription Devices
1.88M
21.63%

Aktionärsstatistik

Aktualisiert: Fri, Feb 6
Aktualisiert: Fri, Feb 6
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Andere
72.98%
Aktionäre
Aktionäre
Anteil
Zhang (Tianyi)
9.19%
Theofilos (Charles Steve)
5.56%
Hilve Holdings Ltd
5.40%
Errico (Thomas J.)
3.83%
The Vanguard Group, Inc.
3.04%
Andere
72.98%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
27.86%
Corporation
8.76%
Investment Advisor
7.46%
Investment Advisor/Hedge Fund
1.59%
Hedge Fund
1.57%
Research Firm
0.02%
Andere
52.74%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
75
727.72K
16.70%
--
2025Q3
75
727.72K
17.61%
-444.98K
2025Q2
70
1.17M
19.50%
-199.13K
2025Q1
65
1.37M
13.77%
+380.78K
2024Q4
69
936.59K
18.00%
-138.83K
2024Q3
59
1.06M
17.69%
+20.62K
2024Q2
62
1.04M
19.14%
+51.56K
2024Q1
68
992.08K
19.07%
-152.78K
2023Q4
66
961.96K
18.72%
+22.04K
2023Q3
73
937.71K
13.66%
+316.94K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Zhang (Tianyi)
734.64K
9.19%
+734.64K
--
May 15, 2025
Theofilos (Charles Steve)
444.53K
5.56%
--
--
Jul 04, 2025
Hilve Holdings Ltd
432.00K
5.4%
+432.00K
--
Aug 15, 2025
Errico (Thomas J.)
306.38K
3.83%
+26.61K
+9.51%
Sep 02, 2025
The Vanguard Group, Inc.
233.47K
2.92%
+1.14K
+0.49%
Sep 30, 2025
Goldberger (Daniel S)
185.90K
2.32%
+1.00K
+0.54%
Dec 02, 2025
Happy Holstein Management, LLC
153.17K
1.92%
--
--
Jul 04, 2025
MAZ Partners, L.P.
115.52K
1.44%
-156.44K
-57.52%
May 13, 2025
Patton (Thomas M)
102.78K
1.29%
+19.01K
+22.69%
Sep 02, 2025
Goldstein (Julie Ann)
101.39K
1.27%
+19.01K
+23.08%
Sep 02, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
Feb 14, 2023
Merger
15→1
KeyAI